These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27263126)

  • 1. A scoring system for predicting the survival prognosis of patients receiving stereotactic body radiation therapy (SBRT) for 1-3 lung metastases.
    Janssen S; Kaesmann L; Rudat V; Rades D
    Lung; 2016 Aug; 194(4):631-5. PubMed ID: 27263126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Qiu H; Katz AW; Chowdhry AK; Usuki KY; Singh DP; Metcalfe S; Cheruvu P; Chen Y; Okunieff P; Milano MT
    Am J Clin Oncol; 2018 Jan; 41(1):53-58. PubMed ID: 26270442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiotherapy Provides Excellent Long-Term Local Control of Very Few Lung Metastases.
    Janssen S; Käsmann L; Rudat V; Rades D
    In Vivo; 2016; 30(2):155-7. PubMed ID: 26912828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in stereotactic body radiotherapy of lung metastases.
    Borm KJ; Oechsner M; Schiller K; Peeken JC; Dapper H; Münch S; Kroll L; Combs SE; Duma MN
    Strahlenther Onkol; 2018 Oct; 194(10):886-893. PubMed ID: 30014235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.
    Tanadini-Lang S; Rieber J; Filippi AR; Fode MM; Streblow J; Adebahr S; Andratschke N; Blanck O; Boda-Heggemann J; Duma M; Eble MJ; Ernst I; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lohaus F; Petersen C; Schrade E; Wendt TG; Wittig A; Høyer M; Ricardi U; Sterzing F; Guckenberger M
    Radiother Oncol; 2017 May; 123(2):182-188. PubMed ID: 28169042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT).
    García-Cabezas S; Bueno C; Rivin E; Roldán JM; Palacios-Eito A
    Clin Transl Oncol; 2015 Aug; 17(8):668-72. PubMed ID: 26022130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
    Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
    J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC).
    Janssen S; Käsmann L; Rudat V; Rades D
    Anticancer Res; 2016 Feb; 36(2):825-8. PubMed ID: 26851047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.